维普期刊资源整合服务平台（V6.5）

94篇 您的检索式：作者名="Becker RH"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Procalcitonin and itscomponent peptides in systemic inflammation 显示文摘	Snide RH Jr Nylen ES Becker KL	1997	J InvestigMed1997，45，9：	1
2	Fluctuat of serum basal insulin levels following single and multiple dosing of insulin glargine显示文摘	Gerich J Becker RH Zhu R	2006	Diabetes Technol Ther2006，8，2：	1
3	Procalcitonin and its component peptides in systemic inflammation:immunochenmical characteriza- tion显示文摘	Snider RH Nylen ES Becker KL	1997	J Investid Med1997，45，：	1
4	Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization显示文摘	Snider RH Jr Nylen ES Becker KL	1997	J Investig Med1997，45，9：	1
5	Procalcitonin and its compo- nent peptides in systemic inflammation: immunochemical charac- terization显示文摘	Snider RH Jr Nylen ES Becker KL	1997	J Investig Med1997，45，9：	1
6	Procalcitonin and its component peptides in syste mic infiammation:immunoche mica1 characterization显示文摘	Snide RH Jr Nylen ES Becker KL	1997	J Investig Med1997，45，：	1
7	Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus 显示文摘	Becker ML Visser LE van Schaik RH	2009	Pharmacog- enomics2009，9，4：	1
8	Procalciton and its component peptides in systemic inflammation; immunochemical characterization显示文摘	Snider RH Jr Nylen ES Becker KI		J Investig Med0，45，9：	1
9	Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization 显示文摘	Snider Rh Jn Nylen ES Becker KL	1997	Invest Med1997，45，：	1
10	Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization 显示文摘	Snider RH Jr Nylen ES Becker KI	1997	J Investig Med1997，45，9：	1
11	Sequential segmental analysis of congenital heart disease显示文摘	Anderson RH Becker AE Freedom RM	1984	Pediatr Cardiol1984，5，：	1
12	Platelet transfusion therapy显示文摘	Becker GA Aster RH	1992	Med Clin North Am1992，56，：	1
13	Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization 显示文摘	Snider RH Jr Nylen ES Becker KL	1997	J Investig Med1997，45，9：	1
14	OCT1 polymor- phism is associated with response and survival time in anti-Parkin- sonian drug users显示文摘	Becker ML Visser LE van Schaik RH	2011	Neurogenetics2011，12，1：	1
15	Thioredoxin reduc- tase as a pathophysiological factor and drug target显示文摘	Becker K Grorner S Schirmer RH	2000	Eur J Bio- chem2000，267，20：	1
16	Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine显示文摘	Gerich J Becker RH Zhu R	2006	Diabetes Teehnol Ther2006，8，2：	1
17	Thioredoxin reductase as a pathophysiological factor and drug target显示文摘	Becker K Gromer S Schirmer RH	2000	Eur J Biochem2000，267，20：	1
18	Procaleitonin and itscomponent peptides in systemic inflammation:immunochemicalcharacterization显示文摘	Snider RH Jr Nylen ES Becker KL	1997	J Investig Med1997，45，9：	1
19	查看详情显示文摘	Ho P K H Kim J S Burroughes J H Becker H Li SFY Brown TM Cacialli F Friend RH		0，，：	1
20	Insulin glulisine,a new rapid -acting insulin analogue, displays a rapid time- action profile in obese non - diabetic subjects 显示文摘	Becker RH Frick AD Burger F	2005	Exp Clin Endocrinol Diabetes2005，113，8：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示